Search

Your search keyword '"Naka, Norifumi"' showing total 435 results

Search Constraints

Start Over You searched for: Author "Naka, Norifumi" Remove constraint Author: "Naka, Norifumi"
435 results on '"Naka, Norifumi"'

Search Results

1. The role of chemotherapy and radiotherapy in localized extraskeletal osteosarcoma

7. Survival analysis of elderly patients with osteosarcoma

11. Publisher Correction: Integrated exome and RNA sequencing of dedifferentiated liposarcoma

12. Author Correction: Establishment of a novel human CIC-DUX4 sarcoma cell line, Kitra-SRS, with autocrine IGF-1R activation and metastatic potential to the lungs

13. Integrated exome and RNA sequencing of dedifferentiated liposarcoma

14. Establishment of a novel human CIC-DUX4 sarcoma cell line, Kitra-SRS, with autocrine IGF-1R activation and metastatic potential to the lungs

16. Supplementary Table S1 from Eribulin Suppresses Clear Cell Sarcoma Growth by Inhibiting Cell Proliferation and Inducing Melanocytic Differentiation Both Directly and Via Vascular Remodeling

17. Data from Eribulin Suppresses Clear Cell Sarcoma Growth by Inhibiting Cell Proliferation and Inducing Melanocytic Differentiation Both Directly and Via Vascular Remodeling

18. Supplementary Figure S1 from Eribulin Suppresses Clear Cell Sarcoma Growth by Inhibiting Cell Proliferation and Inducing Melanocytic Differentiation Both Directly and Via Vascular Remodeling

19. Ten-year follow-up results of perioperative chemotherapy with doxorubicin and ifosfamide for high-grade soft-tissue sarcoma of the extremities: Japan Clinical Oncology Group study JCOG0304

20. WT1 Trio Peptide-Based Cancer Vaccine for Rare Cancers Expressing Shared Target WT1

23. Prospective comparison of various radiological response criteria and pathological response to preoperative chemotherapy and survival in operable high-grade soft tissue sarcomas in the Japan Clinical Oncology Group study JCOG0304

24. Clinical outcome of primary giant cell tumor of bone after curettage with or without perioperative denosumab in Japan: from a questionnaire for JCOG 1610 study

26. Japanese Orthopaedic Association (JOA) clinical practice guidelines on the management of soft tissue tumors 2020 - Secondary publication

28. WT1 epitope‑specific IgG and IgM antibodies for immune‑monitoring in patients with advanced sarcoma treated with a WT1 peptide cancer vaccine

30. A case report of pancreatic metastasis from synovial sarcoma successfully treated by metastasectomy with adjuvant chemotherapy

31. Rectotumoral fistula formation occurring more than 5 years after carbon ion radiotherapy for sacral chordoma: A case report

35. Giant cell tumor of bone – Analysis of 213 cases involving extra‐craniofacial bones

40. Validation of radiographic response evaluation criteria of preoperative chemotherapy for bone and soft tissue sarcomas: Japanese Orthopaedic Association Committee on Musculoskeletal Tumors Cooperative Study

41. Efficacy and safety of TAS-115, a novel oral multi-kinase inhibitor, in osteosarcoma: an expansion cohort of a Phase I study

43. Comprehensive molecular and clinicopathological profiling of desmoid tumours

47. Standard Treatment Remains the Recommended Approach for Patients with Bone Sarcoma Who Underwent Unplanned Surgery: Report from the Japanese Musculoskeletal Oncology Group

49. PhaseIIclinical trial of pazopanib for patients with unresectable or metastatic malignant peripheral nerve sheath tumors

50. Prognostic factors and skeletal‑related events in patients with bone metastasis from gastric cancer

Catalog

Books, media, physical & digital resources